These observations are consistent with our initial hypothesis that PERK signaling activation is able to augment NRF2 dependent signaling, with the potential of reducing cell damage and promoting cell growth in COPD lungs. Here, NFE2L2 is linked to chronic obstructive pulmonary disease.